AEON Biopharma, Inc. (AEON )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol AEON
- Company AEON Biopharma, Inc.
- Price $1.16
- Changes Percentage 16
- Change 0.16
- Day Low $0.98
- Day High $1.31
- Year High $1.45
- Year Low $0.38
- Market Cap $13,723,193
- Price Avg 50 EMA (D) $1.12
- Price Avg 200 EMA (D) $0.92
- Exchange AMEX
- Volume 293,473
- Average Volume 157,442
- Open $0.98
- Previous Close $1
- EPS 2.98
- PE 0.39
- Earnings Announcement 2026-04-01 12:00:00
- Shares Outstanding $11,830,339
Company brief: AEON BIOPHARMA, INC. (AEON )
- Healthcare
- Biotechnology
- Mr. Marc Forth
- http://www.aeonbiopharma.com
- US
- N/A
- 07-24-2023
- US00791X1000
AEON Biopharma, Inc., a biopharmaceutical company, focuses on the development botulinum toxins for the treatment of debilitating medical conditions. It also develops 900 kDabotulinum toxin complex, ABP-450, for migraine, cervical dystonia, and gastroparesis. The company was formerly known as ALPHAEON Corporation and changed its name to AEON Biopharma, Inc. in December 2019. AEON Biopharma, Inc. was incorporated in 2012 and is headquartered in Newport Beach, California.